373 related articles for article (PubMed ID: 30588882)
1. Development and Characterization of Olanzapine Loaded Poly(lactide-coglycolide) Microspheres for Depot Injection: In vitro and In vivo Release Profiles.
Pervaiz F; Ahmad M; Li L; Murtaza G
Curr Drug Deliv; 2019; 16(4):375-383. PubMed ID: 30588882
[TBL] [Abstract][Full Text] [Related]
2. Microsphere delivery of Risperidone as an alternative to combination therapy.
D'Souza S; Faraj J; DeLuca P
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
[TBL] [Abstract][Full Text] [Related]
3. Study on the Slow-Release Mometasone Furoate Injection of PLGA for the Treatment of Knee Arthritis.
Liang Y; Zhang J; Zhao X; Wang M; Ding S; Wang Y; Chen Y; Liu J
Curr Drug Deliv; 2021; 18(3):357-368. PubMed ID: 32940181
[TBL] [Abstract][Full Text] [Related]
4. Preparation, characterization, and in vitro release studies of insulin-loaded double-walled poly(lactide-co-glycolide) microspheres.
Ansary RH; Rahman MM; Awang MB; Katas H; Hadi H; Doolaanea AA
Drug Deliv Transl Res; 2016 Jun; 6(3):308-18. PubMed ID: 26817478
[TBL] [Abstract][Full Text] [Related]
5. Zero order controlled release delivery of cholecalciferol from injectable biodegradable microsphere: In-vitro characterization and in-vivo pharmacokinetic studies.
Vora L; V G S; Vavia P
Eur J Pharm Sci; 2017 Sep; 107():78-86. PubMed ID: 28629804
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: Zero-order release formulation.
Su ZX; Shi YN; Teng LS; Li X; Wang LX; Meng QF; Teng LR; Li YX
Pharm Dev Technol; 2011 Aug; 16(4):377-84. PubMed ID: 20370594
[TBL] [Abstract][Full Text] [Related]
7. Sustained release of risperidone from biodegradable microspheres prepared by in-situ suspension-evaporation process.
An T; Choi J; Kim A; Lee JH; Nam Y; Park J; Sun Bk; Suh H; Kim CJ; Hwang SJ
Int J Pharm; 2016 Apr; 503(1-2):8-15. PubMed ID: 26899975
[TBL] [Abstract][Full Text] [Related]
8. Development of andrographolide loaded PLGA microspheres: optimization, characterization and in vitro-in vivo correlation.
Jiang Y; Wang F; Xu H; Liu H; Meng Q; Liu W
Int J Pharm; 2014 Nov; 475(1-2):475-84. PubMed ID: 25219858
[TBL] [Abstract][Full Text] [Related]
9. Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere.
Su Z; Sun F; Shi Y; Jiang C; Meng Q; Teng L; Li Y
Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1251-6. PubMed ID: 19881277
[TBL] [Abstract][Full Text] [Related]
10. Biodegradable PLGA microspheres as a sustained release system for a new luteinizing hormone-releasing hormone (LHRH) antagonist.
Du L; Cheng J; Chi Q; Qie J; Liu Y; Mei X
Chem Pharm Bull (Tokyo); 2006 Sep; 54(9):1259-65. PubMed ID: 16946531
[TBL] [Abstract][Full Text] [Related]
11. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
Xu H; Zhong H; Liu M; Xu C; Gao Y
Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119
[TBL] [Abstract][Full Text] [Related]
12. Effects of formulation parameters on encapsulation efficiency and release behavior of thienorphine loaded PLGA microspheres.
Yang Y; Gao Y; Mei X
Pharm Dev Technol; 2013; 18(5):1169-74. PubMed ID: 21967467
[TBL] [Abstract][Full Text] [Related]
13. Preparation of ONO-1301-loaded poly(lactide-co-glycolide) microspheres and their effect on nerve conduction velocity.
Hazekawa M; Sakai Y; Yoshida M; Haraguchi T; Morisaki T; Uchida T
J Pharm Pharmacol; 2011 Mar; 63(3):362-8. PubMed ID: 21749383
[TBL] [Abstract][Full Text] [Related]
14. Engineered PLGA microspheres for extended release of brexpiprazole:
Wu B; Wu L; He Y; Yin Z; Deng L
Drug Dev Ind Pharm; 2021 Jun; 47(6):1001-1010. PubMed ID: 34032181
[TBL] [Abstract][Full Text] [Related]
15. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres.
Jiang G; Qiu W; DeLuca PP
Pharm Res; 2003 Mar; 20(3):452-9. PubMed ID: 12669968
[TBL] [Abstract][Full Text] [Related]
16. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
17. Goserelin Acetate Loaded Poloxamer Hydrogel in PLGA Microspheres: Core-Shell Di-Depot Intramuscular Sustained Release Delivery System.
Qi P; Bu R; Zhang H; Yin J; Chen J; Zhang A; Gou J; Yin T; Zhang Y; He H; Wang P; Tang X; Wang Y
Mol Pharm; 2019 Aug; 16(8):3502-3513. PubMed ID: 31251642
[TBL] [Abstract][Full Text] [Related]
18. Raloxifene-/raloxifene-poly(ethylene glycol) conjugate-loaded microspheres: A novel strategy for drug delivery to bone forming cells.
Kavas A; Keskin D; Altunbaş K; Tezcaner A
Int J Pharm; 2016 Aug; 510(1):168-83. PubMed ID: 27343363
[TBL] [Abstract][Full Text] [Related]
19. Development and Evaluation of Ropivacaine Loaded Poly(Lactic-Co-Glycolic Acid) Microspheres with Low Burst Release.
Zhao X; Gao Y; Tang X; Lei W; Yang Y; Yu F; Liu Y; Yang M; Wang Y; Gong W; Li Z; Gao C; Mei X
Curr Drug Deliv; 2019; 16(6):490-499. PubMed ID: 31132975
[TBL] [Abstract][Full Text] [Related]
20. Physicochemical Characterization and Pharmacokinetics of Agomelatine-Loaded PLGA Microspheres for Intramuscular Injection.
Zhang H; Pu C; Wang Q; Tan X; Gou J; He H; Zhang Y; Yin T; Wang Y; Tang X
Pharm Res; 2018 Nov; 36(1):9. PubMed ID: 30411255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
